Ovádi, Judit

Link to this page

http://farfar.pharmacy.bg.ac.rs/APP/faces/author.xhtml?author_id=b70d6860-af69-485c-a0ba-d86d7e664260&item_offset=0&project_offset=0&sort_by=dc.date.issued
Authority KeyName Variants
b70d6860-af69-485c-a0ba-d86d7e664260
  • Ovádi, Judit (1)
Projects

Author's Bibliography

Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design

Bouchet, Samuel; Linot, Camille; Ružić, Dušan; Agbaba, Danica; Fouchaq, Benoit; Roche, Joëlle; Nikolić, Katarina; Cuendet, Muriel; Ovádi, Judit; Blanquart, Christophe; Bertrand, Philippe

(European Cooperation in Science and Technology (COST), 2017) 

TY  - CONF
AU  - Bouchet, Samuel
AU  - Linot, Camille
AU  - Ružić, Dušan
AU  - Agbaba, Danica
AU  - Fouchaq, Benoit
AU  - Roche, Joëlle
AU  - Nikolić, Katarina
AU  - Cuendet, Muriel
AU  - Ovádi, Judit
AU  - Blanquart, Christophe
AU  - Bertrand, Philippe
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4926
PB  - European Cooperation in Science and Technology (COST)
C3  - EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017
T1  - Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design
SP  - 19
EP  - 19
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4926
ER  - 
@conference{
author = "Bouchet, Samuel and Linot, Camille and Ružić, Dušan and Agbaba, Danica and Fouchaq, Benoit and Roche, Joëlle and Nikolić, Katarina and Cuendet, Muriel and Ovádi, Judit and Blanquart, Christophe and Bertrand, Philippe",
year = "2017",
publisher = "European Cooperation in Science and Technology (COST)",
journal = "EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017",
title = "Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design",
pages = "19-19",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4926"
}
Bouchet, S., Linot, C., Ružić, D., Agbaba, D., Fouchaq, B., Roche, J., Nikolić, K., Cuendet, M., Ovádi, J., Blanquart, C.,& Bertrand, P.. (2017). Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design. in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017
European Cooperation in Science and Technology (COST)., 19-19.
https://hdl.handle.net/21.15107/rcub_farfar_4926
Bouchet S, Linot C, Ružić D, Agbaba D, Fouchaq B, Roche J, Nikolić K, Cuendet M, Ovádi J, Blanquart C, Bertrand P. Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design. in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017. 2017;:19-19.
https://hdl.handle.net/21.15107/rcub_farfar_4926 .
Bouchet, Samuel, Linot, Camille, Ružić, Dušan, Agbaba, Danica, Fouchaq, Benoit, Roche, Joëlle, Nikolić, Katarina, Cuendet, Muriel, Ovádi, Judit, Blanquart, Christophe, Bertrand, Philippe, "Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design" in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017 (2017):19-19,
https://hdl.handle.net/21.15107/rcub_farfar_4926 .